Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug trial offers hope for Hard-to-Treat bowel disease

NCT ID NCT06964113

Recruiting now Disease control Sponsor: Eisai Korea Inc. Source: ClinicalTrials.gov ↗

Summary

This study is testing how well and how safely the drug filgotinib works for Korean adults with moderate to severe ulcerative colitis, a chronic inflammatory bowel disease. It is for people whose symptoms have not been controlled well by standard medications like steroids or other biologic drugs. The main goal is to see if the drug can help patients achieve clinical remission, meaning their symptoms go away, by weeks 10 or 22 of treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Eisai Site #1

    RECRUITING

    Seoul, South Korea

  • Eisai Site #10

    RECRUITING

    Seoul, South Korea

  • Eisai Site #11

    RECRUITING

    Yangsan, South Korea

  • Eisai Site #12

    RECRUITING

    Seoul, South Korea

  • Eisai Site #13

    RECRUITING

    Busan, South Korea

  • Eisai Site #14

    RECRUITING

    Seoul, South Korea

  • Eisai Site #15

    RECRUITING

    Busan, South Korea

  • Eisai Site #16

    RECRUITING

    Gyeonggi-do, South Korea

  • Eisai Site #18

    NOT_YET_RECRUITING

    Jungnam, South Korea

  • Eisai Site #19

    NOT_YET_RECRUITING

    Seoul, South Korea

  • Eisai Site #2

    RECRUITING

    Daejeon, South Korea

  • Eisai Site #3

    RECRUITING

    Seoul, South Korea

  • Eisai Site #4

    RECRUITING

    Suwon, South Korea

  • Eisai Site #5

    RECRUITING

    Seoul, South Korea

  • Eisai Site #6

    RECRUITING

    Daegu, South Korea

  • Eisai Site #7

    RECRUITING

    Jungnam, South Korea

  • Eisai Site #8

    RECRUITING

    Busan, South Korea

  • Eisai Site #9

    RECRUITING

    Seoul, South Korea

Conditions

Explore the condition pages connected to this study.

ULCERATIVE COLITIS